Topical insulin in pediatric neurotrophic keratopathy associated with CIPA syndrome

J AAPOS. 2025 Apr;29(2):104120. doi: 10.1016/j.jaapos.2025.104120. Epub 2025 Feb 6.

Abstract

We present a case, with a 2-year follow-up, of the use of topical insulin in managing neurotrophic keratopathy in a 3-year-old boy diagnosed with congenital insensitivity to pain with anhidrosis (CIPA). Initially, the patient had a corneal perforation in the right eye, for which he underwent tectonic amniotic membrane transplantation. On examination, a central corneal ulcer with stromal infiltration was identified in the left eye, accompanied by a complete absence of corneal sensation in both eyes. Systemic features consistent with CIPA, such as the absence of a normal response to pain stimuli, anhidrosis, and self-injurious behavior, were also observed. Topical insulin, along with preservative-free lubricants (PF-L) and prophylactic antibiotics, was prescribed for both eyes. Within 2 weeks, the left corneal ulcer had healed, and treatment with topical insulin and PF-L was continued. After a 2-year follow-up, the left cornea exhibited a stable small paracentral nebula, whereas the right cornea showed a central non-adherent leucoma. No recurrence of corneal ulceration occurred.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Child, Preschool
  • Cornea* / innervation
  • Corneal Diseases* / drug therapy
  • Corneal Diseases* / etiology
  • Corneal Ulcer* / drug therapy
  • Corneal Ulcer* / etiology
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents* / administration & dosage
  • Insulin* / administration & dosage
  • Male
  • Ophthalmic Solutions

Substances

  • Insulin
  • Hypoglycemic Agents
  • Ophthalmic Solutions